Johnson & Johnson Market Cap

Johnson & Johnson has a market cap or net worth of $611.9 billion as of October 14, 2026. It is the 22nd most valuable company in the world and the 17th biggest in the United States. Its market cap has increased by 33.09% in one year.

Market Cap

611.90B

Enterprise Value

640.18B

1-Year Change

33.09%

Global Rank

#22

Country Rank

#17 United States

ChartMarket Cap Chart

Chart

Since December 1, 1998, Johnson & Johnson's market cap has increased from $108.92B to $611.90B, an increase of 461.80%. That is a compound annual growth rate of 6.38%.

Market Cap History

Date	Market Cap	% Change
Oct 14, 2026	611.90B	22.72%
Dec 31, 2025	498.60B	43.20%
Dec 31, 2024	348.19B	-7.72%
Dec 29, 2023	377.32B	-18.30%
Dec 30, 2022	461.85B	2.55%
Dec 31, 2021	450.36B	8.70%
Dec 31, 2020	414.31B	7.92%
Dec 31, 2019	383.91B	10.92%
Dec 31, 2018	346.11B	-7.79%
Dec 29, 2017	375.36B	19.76%
Dec 30, 2016	313.43B	10.28%
Dec 31, 2015	284.22B	-2.90%
Dec 31, 2014	292.70B	13.27%
Dec 31, 2013	258.42B	33.02%
Dec 31, 2012	194.27B	8.47%
Dec 30, 2011	179.09B	5.44%
Dec 31, 2010	169.86B	-4.42%
Dec 31, 2009	177.71B	7.05%
Dec 31, 2008	166.00B	-13.03%
Dec 31, 2007	190.88B	-0.28%
Dec 29, 2006	191.42B	7.06%
Dec 30, 2005	178.79B	-5.00%
Dec 31, 2004	188.21B	22.75%
Dec 31, 2003	153.33B	-3.90%
Dec 31, 2002	159.55B	-11.43%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
Eli Lilly and Company	1.05T
AbbVie	488.55B
Merck & Co.	359.22B
Novartis AG	272.48B
AstraZeneca	246.25B
Amgen	224.29B
Gilead Sciences	187.44B
Novo Nordisk	169.11B

Market Cap Rankings